PLUS1
124.24
1.82 (1.49%)
1.82 (1.49%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agilent Technologies | A | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.82 | 1.49% | 124.24 | 13:11:31 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 122.26 | 122.01 | 124.32 | 122.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,625 | 548,564 | $ 123.16 | $ 67,559,129 | 1,712,904 | 61.63 - 136.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:11:32 | 4 | $ 124.25 | USD |
Agilent Technologies Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 38.06B | 306.85M | 305.73M | $ 5.34B | $ 714.89M | 2.30 | 54.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.72 | 0.58% | - | - |
Agilent Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/22/2021 | 15:08 | Seeking Alpha | Agilent’s pharmDx assay approved for use in non-small cell.. |
| 2/22/2021 | 13:46 | Business Wire | Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA.. |
| 2/18/2021 | 18:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/18/2021 | 18:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/18/2021 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/18/2021 | 17:36 | Business Wire | Agilent Ranks No. 2 on Barron’s List of America’s Most.. |
| 2/18/2021 | 08:00 | Business Wire | Agilent Announces Immunoassay Kit to Detect SARS-CoV-2.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical A Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 132.79 | 136.98 | 120.41 | 126.99 | 2,176,732 | -8.55 | -6.44% |
| 1 Month | 122.08 | 136.98 | 118.11 | 124.52 | 1,757,666 | 2.16 | 1.77% |
| 3 Months | 115.63 | 136.98 | 113.16 | 122.19 | 1,689,277 | 8.61 | 7.45% |
| 6 Months | 98.78 | 136.98 | 94.76 | 113.75 | 1,530,493 | 25.46 | 25.77% |
| 1 Year | 82.98 | 136.98 | 61.63 | 94.78 | 1,815,906 | 41.26 | 49.72% |
| 3 Years | 71.00 | 136.98 | 60.42 | 78.46 | 2,040,108 | 53.24 | 74.99% |
| 5 Years | 36.65 | 136.98 | 36.47 | 69.43 | 1,914,581 | 87.59 | 238.99% |
Agilent Technologies Description
| Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations. |
